Portal de investigación
ENFERMEDAD DE GAUCHER TIPO 1. VARIABILIDAD FENOTIPICA DE LAS ALTERACIONES OSEAS Y SU ESTUDIO MEDIENTE TECNICAS DE GENOMICA, TRANSCRIPTONICA Y PROTEOMICA.
Datos básicos
- NumeroConcesion:
- FUNDACION ARECES ESPAÑA
- Año inicial:
- 2010
- Año final:
- 2013
Objetivos del proyecto
FINALIZADO
Documentos
- No hay documentos
Participantes
-
Francisco España Furio
Investigador Principal
Grupos
-
Hemostasia, Trombosis, Arteriosclerosis y Biología vascular
Investigador Principal
Pilar Medina Badenes
Financiadores
Resultados del Proyecto
Current knowledge of genetic risk factors for venous thrombosis
SILVIA NAVARRO ROSALES; (...); PILAR MEDINA BADENES
Capítulo de un Libro. 2014
"In Vitro" Evaluation of Energy-Based Sealing of Graft Side Branches in Bypass Surgery.
Miralles, Manuel; (...); Clara, Albert
Article. 10.1007/s00268-023-07107-0. 2023
349 - Clinical usefulness of eight novel monoclonal antibodies against prostate-specific antigen (PSA) to differentiate prostate cancer and benign prostate hyperplasia. Measurement of different PSA molecular forms with specific immunoassays
S. Navarro; (...); P. Medina-Badenes
Article. 10.1016/S1569-9056(17)30413-X. 2017
A MODIFICATION OF CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY TO EXPLORE NEW COFACTORS OF ACTIVATED PROTEIN C IN PLASMA
Martos, L.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50233-2. 2014
A NOVEL TISSUE MICRORNA SIGNATURE FOR ARRHYTHMOGENIC CARDIOMYOPATHY
Zorio, E.; (...); Medina, P.
Article. 10.1016/S0049-3848(14)50269-1. 2014
A novel tissue microRNA signature for arrythmogenic cardiomyopathy.
Zorio, E; (...); Medina, P.
Article. 2014
A predictive model for prostate cancer incorporating PSA molecular forms and age.
Oto J; (...); Navarro S
Article. 10.1038/s41598-020-58836-4. 2020
A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with Aneurysms.
Weronska A; (...); Wypasek E
Article. 10.3390/genes13050733. 2022
A simplified assay for quantification of circulating activated protein C levels
Medina, P.; (...); Espana, F.
Article. 2013
A simplified assay for quantification of circulating activated protein C levels
Bonet, Elena; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.025. 2012
A simplified assay for the quantification of circulating activated protein C
Martos L; (...); Medina P
Article. 10.1016/j.cca.2016.05.025. 2016
a2-Macroglobulin is a significant in vivo inhibitor of activated protein C and low levels of APC:a2M are associated with venous thromboembolism
Navarro S; (...); Medina P
Article. 2018
Activated protein C assays: a review.
Review. 10.1016/j.cca.2019.11.005. 2020
Advances in the genetics of haemostatic monogenic diseases
España, Francisco; (...); Estellés, Amparo
Article. 2011
alpha(2)-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC: alpha M-2 Levels Are Associated with Venous Thromboembolism
Martos, L; (...); Medina, P
Article. 10.1055/s-0038-1629902. 2018
Angioedema in patients with urticaria is associated with an increase in thrombin generation peak
Valle, DGK; (...); Rosales, SN
Meeting Abstract. 2018
Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency
Navarro-Fernandez, J; (...); Vicente, V
Article. 10.1160/TH15-11-0871. 2016
Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice
Bernardo, Angel; (...); Medina, Pilar
Article. 10.3390/jcm11123345. 2022
Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma.
Vila V; (...); España F
Article. 10.1111/hae.12044. 2013
Association of haplotypes (H) 1 and 3 of the endothelial protein c receptor gene (PROCR) with venous thromboembolism
Bonet, Elena; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.027. 2012
Association of haplotypes (H) 1 and 3 of the endothelial protein C receptor gene (PROCR) with venous thromboembolism
Navarro, S.; (...); Medina, P.
Article. 2013
Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
Navarro S; (...); España F
Article. 10.1161/ATVBAHA.113.301360. 2013
Biomarkers of venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis (HISPALIS study)
Candelera, RO; (...); Badenes, PM
Meeting Abstract. 2021
Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).
Otero, Remedios; (...); Medina, Pilar
Article. 10.3390/cancers14112771. 2022
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Calprotectin as a new inflammatory marker of abdominal aortic aneurysm: A pilot study.
Plana E; (...); Miralles M
Article. 10.1177/1358863X241231494. 2024
Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
Herranz, R; (...); Medina, P
Review. 10.3390/cancers13061448. 2021
COMBINED DEFICIENCY OF PROTEIN C, PROTEIN S AND ANTITHROMBIN IN PATIENTS WITH MESENTERIC OR PORTAL VENOUS THROMBOSIS WITH OR WITHOUT HEPATIC CIRRHOSIS
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50197-1. 2014
Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method
Cabrera, N.; (...); Aznar, J. A.
Article. 2013
Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
Cabrera N; (...); Aznar JA
Article. 10.1111/hae.12203. 2013
Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation
Ramon-Nunez, Luis A.; (...); Navarro, Silvia
Article. 10.1371/journal.pone.0187005. 2017
CONTRIBUTION OF NETOSIS IN ADVANCED STAGES OF HIGH-GRADE SEROUS OVARIAN CANCER: DIAGNOSTIC IMPLICATIONS
Alexandre, J. Mari; (...); Gilabert-Estelles, J.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.604. 2021
Changes in sleep-disordered breathing from the acute to the stable phase of pulmonary embolism and impact of right ventricular dysfunction: preliminary findings of ESAET study
Ortega, AG; (...); Martinez-Garcia, MA
Meeting Abstract. 10.1183/13993003.congress-2020.4974. 2020
Characterization of variants in the glucosylceramide synthase gene and their association with type 1 Gaucher disease severity.
Alfonso P; (...); Giraldo P
Article. 10.1002/humu.22381. 2013
Delving into the clinical impact of NETs in pediatric cancer.
Benavent N; (...); Medina P
Article. 10.1038/s41390-024-03437-4. 2024
Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease
Andrade-Campos, M; (...); Giraldo, P
Article. 10.1186/s13023-017-0627-z. 2017
Differences in the expression of microRNAs 16-5p and 451a after acute exercise in patients with thrombosis versus healthy subjects
Lopez, Veronica Sanchez; (...); Candelera, Remedios Otero
Meeting Abstract. 10.1183/13993003.congress-2024.PA535. 2024
Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension
Oto, Julia; (...); Albert Barbera, Joan
Meeting Abstract. 10.1183/13993003.congress-2019.PA5050. 2019
Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer
Oto, Julia; (...); Otero, Remedios
Meeting Abstract. 10.1183/13993003.congress-2021.PA593. 2021
Differential Gene Expression of Cardiac Ion Channels in Human Dilated Cardiomyopathy
Micaela Molina-Navarro, Maria; (...); Rivera, Miguel
Article. 2013
Differential gene expression of cardiac ion channels in human dilated cardiomyopathy.
Molina-Navarro MM; (...); Rivera M
Article. 10.1371/journal.pone.0079792. 2013
Dysregulated neutrophil extracellular traps and haemostatic biomarkers as diagnostic tools and therapeutic targets in periprosthetic joint infection.
Oto, Julia; (...); Medina, Pilar
Article. 10.1302/0301-620X.106B9.BJJ-2024-0187.R1. 2024
Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels.
Medina P; (...); España F
Article. 10.1160/TH11-07-0510. 2012
Extrathoracic Aneurysms in Marfan Syndrome: A Systematic Review of the Literature.
Requejo-Garcia, Lucia; (...); Miralles-Hernandez, Manuel
Article. 10.1016/j.avsg.2022.08.005. 2022
Familial left ventricular noncompaction associated with a novel mutation in the alpha-cardiac actin gene.
Rodríguez-Serrano M; (...); Zorio E
Letter. 10.1016/j.rec.2014.05.015. 2014
Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene.
Carrasco JI; (...); Zorio E
Letter. 10.1016/j.recesp.2012.03.014. 2012
Functional analysis of the thrombomodulin gene c.1418C > T polymorphism. Its association with venous thrombosis
Bonet, E.; (...); Navarro, S.
Article. 2013
Functional Analysis of Two Haplotypes of the Human Endothelial Protein C Receptor Gene
Medina P; (...); España F
Article. 10.1161/ATVBAHA.113.302518. 2014
FUNCTIONAL ANALYSIS OF TWO HAPLOTYPES OF THE HUMAN ENDOTHELIAL PROTEIN C RECEPTOR GENE (PROCR)
Bonet, E.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50053-9. 2014
Haplotypes of the endothelial protein C receptor gene and Behçet's disease.
Navarro S; (...); España F
Article. 10.1016/j.thromres.2011.07.032. 2012
Haplotypes of the endothelial protein C receptor gene and circulating protein C levels
Martos, L.; (...); Medina, P.
Article. 2013
Haplotypes of the endothelial protein C receptor gene and circulating protein C levels
Martos, Laura; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.026. 2012
Heart Failure Induces Significant Changes in Nuclear Pore Complex of Human Cardiomyocytes
Tarazon, Estefania; (...); Portoles, Manuel
Article. 2012
Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes.
Tarazón E; (...); Portolés M
Article. 10.1371/journal.pone.0048957. 2012
Identification and validation of plasma micrornas involved in venous and arterial thrombosis
Ramon, L. A.; (...); Navarro, S.
Meeting Abstract. 2015
IDENTIFICATION OF 58 MUTATIONS (26 NEW) IN 94 OF 109 BEING TESTED WITH PROTEIN DEFICIENCY C. SETH WORKING GROUP
Fernandez-Pardo, A.; (...); Navarro, S.
Meeting Abstract. 2019
Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency
Martos, L; (...); Spanish Soc Thrombosis Haemostasis
Article. 10.1055/s-0039-1692440. 2019
IDENTIFICATION OF 6 MUTATIONS IN THE PROTEIN C GENE (PROC) IN A PANEL OF 83 SPANISH FAMILIES WITH PROTEIN C DEFICIENCY
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50254-X. 2014
IDENTIFICATION OF A MICRORNA PROFILE RELATED TO HYPERTROPHIC CARDIOMYOPATHY
Plana, E.; (...); Medina, P.
Meeting Abstract. 10.1016/S0049-3848(14)50064-3. 2014
Identification of a microRNA profile related to hypertrophic cardiomyopathy. PUBLICACION: THROMBOSIS RESEARCH.
Plana, E; (...); Medina, P.
Article. 2014
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN ARTERIAL THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50273-3. 2014
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN VENOUS THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50271-X. 2014
IDENTIFICATION OF A PROFILE OF CLASSES OF CIRCULATING LIPIDS ASSOCIATED WITH THE VENOUS THROMBOEMBOLISM
Fernandez-Pardo, A.; (...); Navarro, S.
Meeting Abstract. 2019
Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
Article. 10.3390/ijms22157913. 2021
Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
Article. 10.3390/biomedicines8110447. 2020
Identification of mutations in the protein C gene in a panel of 65 Spanish families with protein C deficiency
Martos, Laura; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.029. 2012
Identification of mutations in the protein C gene in a panel of 83 Spanish families with protein C deficiency
Martos, L.; (...); Navarro, S.
Article. 2013
Identification of Novel microRNA Profiles Dysregulated in Plasma and Tissue of Abdominal Aortic Aneurysm Patients
Plana E; (...); Miralles M
Article. 10.3390/ijms21134600. 2020
Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C
Martos L; (...); Medina P
Article. 10.3390/ijms21165651. 2020
Increased circulating dna, calprotectin and mieloperoxidase, as neutrophil extracellular trap markers, are risk factors for deep vein thrombosis
Martos, L.; (...); Medina, P.
Meeting Abstract. 2015
INCREASED LEVELS OF FREE CIRCULATING DNA AND DNASE 1 ACTIVITY IN PLASMA IS ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLISM
Oto, J.; (...); Medina, P.
Meeting Abstract. 2019
Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients' biofluids: Potential role in disease diagnosis and management.
Tomás-Pérez S; (...); Gilabert-Estellés J
Article. 10.3389/fimmu.2023.1111344. 2023
INSM1 immunohistochemical expression in a large cohort of Ewing sarcoma family of tumours
Llombart-Bosch, A; (...); Picci, P
Meeting Abstract. 2019
Intra-plaque calcium and its relation with the progression of carotid atheromatous disease.
Miralles, Manuel; (...); Plana, Emma
Article. 10.23736/S0392-9590.22.04872-6. 2022
Involvement of the coagulation system in hereditary angioedema
Echevarria, EI; (...); De Rojas, DHF
Meeting Abstract. 2018
LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer
Oto, Julia; (...); Medina, Pilar
Article. 10.1007/s00345-022-04136-7. 2022
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.
Deguchi, H; (...); Griffin, JH
Article. 10.1002/rth2.12018. 2017
Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behcet's disease
Maria Ricart, Jose; (...); Vaya, Amparo
Article. 2013
Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.
Ricart JM; (...); Vayá A
Article. 10.3233/CH-2012-1564. 2013
Metabolomic study for the identification of symptomatic carotid plaque biomarkers
Botello-Marabotto, Marina; (...); Miralles, Manuel
Article. 10.1016/j.talanta.2024.127211. 2025
MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors
Braza-Boïls A; (...); Estellés A
Article. 10.1093/humrep/deu019. 2014
MICRORNA EXPRESSION PROFILE IN EPICARDIAL FAT IN SUDDEN CARDIAC DEATH FROM CORONARY ARTERY DISEASE
Braza-Boils, A.; (...); Zorio, E.
Article. 2014
Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility
Mari-Alexandre, J; (...); Gilabert-Estelles, J
Article. 10.1016/j.fertnstert.2017.11.036. 2018
microRNAs and angiogenesis in endometriosis
Mari-Alexandre, J; (...); Gilabert-Estelles, J
Article. 10.1016/S0049-3848(15)50439-8. 2015
microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors
Article. 10.3390/cancers12061536. 2020
MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
Article. 10.3390/ijms21030840. 2020
MicroRNAs as predictors of chronic thromboembolic pulmonary hypertension
Otero Candelera, Remedios; (...); Sanchez Lopez, Veronica
Meeting Abstract. 10.1183/13993003.congress-2023.OA4831. 2023
microRNAs Expression in Endometriosis and Their Relation to Angiogenic Factors EDITORIAL COMMENT
Ramon, Luis A.; (...); Estelles, Amparo
Article. 10.1097/OGX.0b013e31824021f9. 2011
microRNAs expression in endometriosis and their relation to angiogenic factors.
Ramón LA; (...); Estelles A
Article. 10.1093/humrep/der025. 2011
microRNAs modulate human tissue factor pathway inhibitor-A (TFPIA) expression in response to androgens in endothelial cells
Rodriguez, A. B. A.; (...); Gonzalez-Conejero, R.
Meeting Abstract. 2015
microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
Ramón LA; (...); Estellés A
Article. 10.1093/humrep/des292. 2012
microRNAs, angiogénesis and fibrinolysis in gynecological pathology
Gilabert-Estellés J; (...); Estelles A
Article. 2012
Modification of a thrombin generation test to identify new cofactors of the protein C pathway in plasma
Martos, L.; (...); Navarro, S.
Meeting Abstract. 2015
Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer.
Castano, Maria; (...); Gilabert-Estelles, Juan
Article. 10.3390/ijms24065995. 2023
New prognostic markers in neuroblastoma.
Navarro S; (...); Noguera R
Article. 10.1517/17530059.2012.704018. 2012
New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression.
Castano, Maria; (...); Gilabert-Estelles, Juan
Editorial Material. 10.3390/ijms24087604. 2023
Novedades en la genética de enfermedades monogénicas hemostásicas
España F; (...); Estelles A
Article. 2011
Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review
Plana, E; (...); Miralles, M
Review. 10.1016/j.thromres.2020.07.039. 2020
Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: what is the impact on lymph node harvest after colon resection for cancer?
Frasson M; (...); Garcia-Granero E
Article. 10.1097/DCR.0b013e31823bd9c1. 2012
Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis
Braza-Boils, A; (...); Martinez, C
Article. 10.1093/humrep/dev204. 2015
Peritoneal Fluid Reduces Angiogenesis-Related MicroRNA Expression in Cell Cultures of Endometrial and Endometriotic Tissues from Women with Endometriosis
Braza-Boils, Aitana; (...); Estelles, Amparo
Article. 2013
Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.
Braza-Boïls A; (...); Estellés A
Article. 10.1371/journal.pone.0062370. 2013
PLASMATIC DNA STIMULATES THE GENERATION OF IN VITRO THROMBIN EVEN IN THE ABSENCE OF EXTRINSIC TISSUE FACTOR AND CAN BE REVERSED WITH DNA'S
Fernandez-Pardo, A.; (...); Medina, P.
Meeting Abstract. 2019
Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
Gilabert-Estellés J; (...); Estellés A
Article. 10.1016/j.thromres.2011.10.007. 2012
Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review
Tarazona N; (...); Cervantes A
Article. 10.2147/OTT.S80879. 2015
Quantitative immunoassay for the measurement of activated protein C complexes with Alfa-2-macroglobulin (APC:alpha M-2)
Espana, F.; (...); Medina, P.
Meeting Abstract. 2015
Red Blood Cell Distribution Width in Patients With Cryptogenic Stroke
Vayá A; (...); Bautista D
Article. 10.1177/1076029614547262. 2015
Role of microRNAs associated with non-alcoholic fatty liver disease in sudden cardiac death from coronary artery disease
Braza-Boils, A.; (...); Zorio, E.
Meeting Abstract. 10.1093/cvr/cvu082.6. 2014
Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; (...); Estelles A
Article. 10.2174/092986712800269362. 2012
Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets.
Oto, Julia; (...); Gotte, Martin
Article. 10.3390/cancers15123125. 2023
Role of the endotelial cell protein C receptor in thrombosis
Medina P; (...); España F
Article. 2012
Screening of microRNAs as possible biomarkers in abdominal aortic aneurysm
Plana, E; (...); Miralles, M
Article. 10.1016/j.angio.2017.09.001. 2018
The endothelial cell protein C receptor: its role in thrombosis.
Navarro S; (...); Medina P
Article. 10.1016/j.thromres.2011.08.001. 2011
The endothelial cell protein C receptor: its role in thrombosis.
Navarro S; (...); Medina P
Article. 10.1016/j.thromres.2011.08.001. 2011
The endothelial protein C receptor is essential for protein C activation in vivo
Bonet, Elena; (...); Espana, Francisco
Article. 10.1016/j.thromres.2012.08.028. 2012
The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population.
Vayá A; (...); Corella D
Article. 10.1089/met.2010.0117. 2011
The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients
Tell-Marti, G; (...); Puig, S
Article. 10.1007/s12035-016-0305-5. 2017
The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.
Tura-Ceide, Olga; (...); Barbera, Joan Albert
Article. 10.1165/rcmb.2024-0282LE. 2025
Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims.
Mari-Alexandre J; (...); Zorio E
Article. 10.1016/j.rec.2017.12.007. 2019
Thrombospondins in human aortic aneurysms.
Plana, Emma; (...); Miralles, Manuel
Article. 10.1002/iub.2610. 2022
Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer
Article. 10.1007/s11934-020-0962-9. 2020
Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study
Article. 10.1016/j.jprot.2020.103723. 2020
VALIDATION OF A MODEL WITH COAGULATION-RELATED MARKERS FOR THE DIAGNOSIS OF PROSTHETIC JOINT INFECTION
Oto, J.; (...); Medina, P.
Meeting Abstract. 2019
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Oto, Julia; (...); Medina, Pilar
Article. 10.1016/j.jprot.2024.105357. 2025
Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
Burgos-Panadero, R; (...); Noguera, R
Article. 10.1186/s12885-019-5693-2. 2019
Detección Y Caracterización De Mutaciones Asociadas Con Un Mayor Riesgo De Trombosis
Autor/es: Silvia Navarro Rosales
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Francisco España Furió
Efecto Del Acenocumarol Sobre El Sistema Anticoagulante De La Proteína C
Autor/es: Ana Rosa Cid Haro
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Estudio Del Papel De Los Micrornas En El Desarrollo De Cáncer De Próstata En Pacientes Con Hiperplasia Benigna
Autor/es: Ana Julia Oto Martínez
Tesis de Máster
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Estudio Funcional De Polimorfismos De La Vía De Activación De La Proteína C
Autor/es: Elena Bonet Estruch
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Identificación De Mutaciones En El Gen De La Proteína C En Un Panel De 44 Familias Españolas Con Deficiencia De Proteína C
Autor/es: Laura Martos Marín
Tesis de Máster
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Identificación De Nuevas Moléculas Con Actividad Anticoagulante Y/O Citoprotectora En La Vía De La Proteína C: Explorando Su Utilidad Clínica.
Autor/es: Álvaro Fernández Pardo
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales; Luís Andrés Ramón Núñez
Influencia De Los Nuevos Anticoagulantes Orales Sobre El Sistema De Activación De La Proteína C
Autor/es: Santiago Bonanad Boix
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Marcadores Circulantes Del Riesgo De Trombosis: Micrornas, Nets Y Generación De Trombina. Su Utilidad Para El Tratamiento Individualizado Del Paciente Con Trombosis
Autor/es: Laura Martos Marín
Tesis Doctoral
Director/es: PILAR MEDINA BADENES; Silvia Navarro Rosales
Campos de Estudio
Cita
ENFERMEDAD DE GAUCHER TIPO 1. VARIABILIDAD FENOTIPICA DE LAS ALTERACIONES OSEAS Y SU ESTUDIO MEDIENTE TECNICAS DE GENOMICA, TRANSCRIPTONICA Y PROTEOMICA. (FUNDACION ARECES ESPAÑA). FUNDACIÓN RAMÓN ARECES. 2010-2013. IP:FRANCISCO ESPAÑA FURIO.